Picton Mahoney Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-699,000
Closed -$27.5M 543
2023
Q2
$27.5M Buy
+699,000
New +$24.7M 1.19% 12

Picton Mahoney Asset Management's ISEE Position: Q3 2023 in Review

Picton Mahoney Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 400,474 shares — an estimated $15.8M sold.

Picton Mahoney Asset Management first reported a position in ISEE in Q2 2022 and held it in 2 quarters. The position peaked at $15.8M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Picton Mahoney Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 400,474 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $15.8M.
  • Picton Mahoney Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Picton Mahoney Asset Management's IVERIC bio, Inc. Common Stock position peaked at $15.8M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Picton Mahoney Asset Management's 13F filing for Q3 2023, filed 6 Nov 2023.